Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
about
Kawasaki syndromeKawasaki diseaseAnti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULESKawasaki disease: an updateKawasaki disease: an updateGiant right coronary artery aneurysms presenting as a cardiac mass: Case report.Kawasaki disease: an update.The role of stress echocardiography in children.Recognition and management of Kawasaki disease.Comparative effectiveness of intravenous immunoglobulin for children with Kawasaki disease: a nationwide cohort study.Kawasaki disease: a case report every otolaryngologist should know.Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients.Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.The Relationship between Coronary Artery Aneurysm and QT Interval Dispersion in Acute Phase of Kawasaki Disease.From atherosclerotic coronary ectasia to aneurysm: a case report and literature review.High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease.Kawasaki disease at British Columbia's Children's Hospital.Prediction of responsiveness or non-responsiveness to treatment of acute Kawasaki disease using 1 gram per kilogram of immunoglobulin--an effective and cost-saving schedule of therapy.Coronary aneurysm and silent myocardial infarction in an adolescent secondary to undiagnosed childhood Kawasaki disease.An overview of surgery options for congenital coronary artery anomalies.Delayed diagnosis of Kawasaki syndrome and thrombosis of a medium-sized aneurysm of the anterior descending coronary artery: case report and literature review.Variability in delivery of care and echocardiogram surveillance of Kawasaki disease.QT Dispersion and T Wave Peak-to-end Interval Dispersion in Children with Kawasaki Disease.The use of anticoagulation in pediatric cardiac disease.Cardiovascular involvement in Kawaski Disease.Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children.Assessment of risk factors for Korean children with Kawasaki disease.Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysmsKawasaki Disease: Current Therapeutic Perspectives.Recognizing Kawasaki disease.Kawasaki disease: update on diagnosis, treatment, and a still controversial etiology.Antibiotic prophylaxis and the medically compromised patient.Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome.Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease.Migraine and Raynaud phenomenon: possible late complications of Kawasaki disease.Do Kawasaki disease patients without coronary artery abnormalities need a long-term follow-up? A myocardial single-photon emission computed tomography pilot study.A comparative study of established z score models for coronary artery diameters in 181 healthy Korean children.Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification.Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis.
P2860
Q24550744-49C4A9FB-6FC0-4483-A1F2-32C190EC1F22Q24654153-53FFB34B-4FA2-48EB-BAA1-3A1B8EC13C6BQ27666345-D3112627-F95D-4E8E-ADB6-C69BF32526CFQ28180597-BAD10539-EA62-45E4-9779-B9218253BBBDQ28192172-B8FB7A81-CD23-47A4-86D7-9D683B49C0AEQ30372783-0F3ED743-7020-42EA-B96A-3557297C2FD1Q33894980-A15079CE-63B8-4CC1-BA76-05C4366F7380Q34026491-63B36288-4A68-4657-993C-0AB26CE0A93CQ34034709-122D0F8D-E6BF-46B3-8E73-86FCDFF6D5F7Q34708567-EDE11A4B-0EB7-45BB-9EE4-0780D74B23D9Q35136875-064A3B56-C7F5-472A-B8F5-688EFD1EEF94Q35548993-3DC6A9A2-0C7F-4655-B894-BBDEFF70F2D9Q35887474-41A86C01-B560-4960-B171-BC843D86D7B3Q36244783-742FC8FF-B8A7-4150-A50E-88CE6C9D8AC4Q36314730-5D16174F-7C38-494F-A083-F37D0AA139BDQ36721749-7F3C0385-FBE7-41A8-B9E6-326C3D606CD0Q37098307-AB2A241D-AE80-4381-8DCD-5FFFFA5C3550Q37289341-F856A1DE-1BC0-4801-9E67-867390B28892Q37409546-05F91EAE-96BB-4F1D-BF56-959918DE1253Q37776155-6D67B12C-73EA-4473-9B6B-6B3603937E90Q37798809-18724DC2-45E7-44F7-A63C-8EBDE512CC69Q37843720-1752644B-8155-4F27-9AC2-75908A8C1BFBQ38011899-599A2A8B-616B-4667-AE20-D920A69BA333Q38764634-88428088-924D-420B-8B84-CCB7A54DF88CQ39653469-73C83D8D-618B-423C-80E8-922C65A8A38DQ39654279-8601FD04-5703-441F-A0FD-7A4FFAE7A39EQ40292278-0CE01E6F-DCE8-415A-A5F8-5B7F23306B24Q40305032-8B789258-F66F-43DC-B5C8-1FABC08C898EQ40408520-15B862BD-EABB-4633-BD2C-FE2668F51814Q40579573-8BCE0604-5473-49B4-90C3-CB1C140C49D3Q40593999-5B2DF788-9694-4C76-987E-001861C13214Q41240167-D499966A-9491-4D58-97DC-F394E8A83159Q41754792-E73F2930-2C4B-40B2-99F9-AFD4C6A0746EQ43202462-DFFC854F-EA5A-4D31-B0A0-58C98B26894AQ43714099-C06F852B-D4AA-40CC-9DAA-843A58409DC6Q43923430-05D42F3E-4B41-427B-94E2-4654C7476F61Q44430463-00AB7718-7289-4C04-BDAC-407240C2A86AQ47155437-CC0E9A7D-24C4-447E-8290-36CE18B7AE5CQ48835164-092A2849-82F7-4DB0-8BCB-AB3B9FB9AD7BQ50991494-D8C05EC7-8D82-46A4-BC3A-07259144AD57
P2860
Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Guidelines for long-term manag ...... g, American Heart Association.
@ast
Guidelines for long-term manag ...... g, American Heart Association.
@en
Guidelines for long-term manag ...... g, American Heart Association.
@nl
type
label
Guidelines for long-term manag ...... g, American Heart Association.
@ast
Guidelines for long-term manag ...... g, American Heart Association.
@en
Guidelines for long-term manag ...... g, American Heart Association.
@nl
prefLabel
Guidelines for long-term manag ...... g, American Heart Association.
@ast
Guidelines for long-term manag ...... g, American Heart Association.
@en
Guidelines for long-term manag ...... g, American Heart Association.
@nl
P2093
P921
P356
P1433
P1476
Guidelines for long-term manag ...... g, American Heart Association.
@en
P2093
Bierman FZ
Ferrieri P
Karchmer AW
Shulman ST
Takahashi M
Taubert KA
P304
P356
10.1161/01.CIR.89.2.916
P407
P577
1994-02-01T00:00:00Z